ADIPOQ and metabolic dysfunction-associated steatotic liver disease: In murine models of NAFLD, administration of adiponectin suppresses liver enlargement and improves the biochemical and histological signs of NAFLD (Tomita et al., 2008; Xu et al., 2003).